Pr OLIVIER Pierre

Prognostic Value of [F]FDG PET Combined with [Ga]Ga-PSMA PET as Pretreatment Imaging in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with [Lu]Lu-PSMA-617.

Bekkhoucha A, Zaragori T, Olivier P, Claudin M, Marie PY, Kunsch J, Verger A, Raymond P, Heyer S, Imbert L, Boursier C

J Nucl Med. 2026 08 13;:

Real-World Outcomes of [Lu]Lu-PSMA-617 in the French Early-Access Program for Patients with Metastatic Castration-Resistant Prostate Cancer.

Bailly C, Vija L, Somme F, Massard V, Barthélémy P, Giraudet AL, Godbert Y, Fléchon A, Girault S, Abadie-Lacourtoisie S, Viala C, Douillet A, Chêne S, Olivier P, Roubaud G

J Nucl Med. 2026 08 6;:

Evaluation of 9-Minute Dual-Energy Peak Time-Reduced 360° CZT Total-Body [Lu]Lu-PSMA SPECT/CT Imaging with Comparisons to [Ga]Ga-PSMA PET.

Boursier C, Heyer S, Zouaoui A, Roth N, Blum R, Claudin M, Olivier P, Marie PY, Verger A, Imbert L

J Nucl Med. 2026 07 23;:

Early Positron Emission Tomography Response-Adapted Treatment in Low-Risk Diffuse Large B-Cell lymphoma: an open label, multicenter, randomised, non-inferiority phase 3 trial.

Michot JM, Bologna S, Bastie JN, Borght TV, Brière J, Ribrag V, Bommier C, Peyrade F, Lebras L, Damaj G, Coso D, Sibon D, Bonnet C, Morschhauser F, Ghesquières H, Fruchart C, Soussain C, Becker S, Olivier P, Julian A, Molina T, Haioun C, Tilly H

Ann Oncol. 2025 11 17;:

Experience of [Lu]Lu-PSMA-617-administration using totally implantable venous access port: simulated experiments and clinical SPECT analyses.

Lombard A, Journo S, Zaragori T, Olivier P, Claudin M, Marie PY, Bros M, Bordonné M, Verger A, Veran N, Citerne Q, Imbert L, Boursier C

EJNMMI Res. 2025 09 26;15(1):121

Prognostic Value of Comprehensive Analysis of Metastatic Prostate Tumor Changes from First to Last [Lu]Lu-PSMA Therapy Injections Through Serial High-Speed Whole-Body 360° Cadmium-Zinc-Telluride SPECT.

Kunsch J, Zaragori T, Olivier P, Claudin M, Marie PY, Raymond P, Heyer S, Verger A, Imbert L, Boursier C

J Nucl Med. 2025 09 11;:

177Lu-PSMA Treatment Monitoring Through Serial Fast Whole-Body Tomoscintigraphies Recorded With a Latest-Generation CZT-Camera.

Boursier C, Olivier P, Claudin M, Marie PY, Imbert L

Clin Nucl Med. 2023 10 1;48(10):e491-e493

[F]DCFPyL PET/CT versus [F]fluoromethylcholine PET/CT in Biochemical Recurrence of Prostate Cancer (PYTHON): a prospective, open label, cross-over, comparative study.

Oprea-Lager DE, Gontier E, García-Cañamaque L, Gauthé M, Olivier P, Mitjavila M, Tamayo P, Robin P, García Vicente AM, Bouyeure AC, Bailliez A, Rodríguez-Fernández A, Mahmoud SB, Vallejo-Casas JA, Maksud P, Merlin C, Blanc-Durand P, Drouet C, Tissot H, Vierasu I, Vander Borght T, Boos E, Chossat F, Hodolic M, Rousseau C

Eur J Nucl Med Mol Imaging. 2023 06 21;:

Phase III study of F-PSMA-1007 versus F-fluorocholine PET/CT for localization of prostate cancer biochemical recurrence: a prospective, randomized, cross-over, multicenter study.

Olivier P, Giraudet AL, Skanjeti A, Merlin C, Weinmann P, Rudolph I, Hoepping A, Gauthé M

J Nucl Med. 2022 11 23;:

PET-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T-cells.

Galtier J, Vercellino L, Chartier L, Olivier P, Tabouret-Viaud C, Mesguich C, Di Blasi R, Durand A, Raffy L, Gros FX, Madelaine I, Meignin V, Mebarki M, Rubio MT, Feugier P, Casasnovas O, Meignan M, Thieblemont C

Haematologica. 2022 06 9;:

Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma.

Vercellino L, Di Blasi R, Kanoun S, Tessoulin B, Rossi C, D'Aveni-Piney M, Obéric L, Bodet-Milin C, Bories P, Olivier P, Lafon I, Berriolo-Riedinger A, Galli E, Bernard S, Rubio MT, Bossard C, Meignin V, Merlet P, Feugier P, Le Gouill S, Ysebaert L, Casasnovas O, Meignan M, Chevret S, Thieblemont C

Blood Adv. 2020 Nov 24;4(22):5607-5615

Head-to-head comparison between digital and analog PET of human and phantom images when optimized for maximizing the signal-to-noise ratio from small lesions.

Salvadori J, Odille F, Verger A, Olivier P, Karcher G, Marie PY, Imbert L

EJNMMI Phys. 2020 Feb 21;7(1):11

Dual time point [F]FLT-PET for differentiating proliferating tissues vs non-proliferating tissues.

Lovinfosse P, Rousseau C, Pierga JY, Bouchet F, Cochet A, Alberini JL, Girault S, Vera P, Olivier P, Uwer L, Cachin F, Scarwell B, Lemonnier J, Fourme E, Mesleard C, Martin AL, Lacœuille F, Couturier OF

EJNMMI Res. 2019 Dec 12;9(1):109

Performance of F-sodium fluoride positron emission tomography with computed tomography to assess inflammatory and structural sacroiliitis on magnetic resonance imaging and computed tomography, respectively, in axial spondyloarthritis.

Raynal M, Bouderraoui F, Ouichka R, Melchior J, Morel O, Blum A, Chary-Valckenaere I, Ngueyon Sime W, Roch V, Maksymowych W, Lambert RG, Olivier P, Loeuille D

Arthritis Res. Ther.. 2019 May 14;21(1):119

Performance of 18F-sodium fluoride positron emission tomography with computed tomography to assess inflammatory and structural sacroiliitis on magnetic resonance imaging in axial spondyloarthritis.

Ouichka R, Bouderraoui F, Raynal M, Melchior J, Morel O, Blum A, Chary-Valckenaere I, Ngueyon Sime W, Roch V, Maksymowych W, Lambert RG, Olivier P, Loeuille D

Clin. Exp. Rheumatol.. 2018 Dec 19;:

Tocilizumab and refractory Takayasu disease: Four case reports and systematic review.

Decker P, Olivier P, Risse J, Zuily S, Wahl D

Autoimmun Rev. 2018 Apr;17(4):353-360

18F-fluorocholine PET/CT in patients with occult biochemical recurrence of prostate cancer: Detection rate, impact on management and adequacy of impact. A prospective multicentre study.

Gillebert Q, Huchet V, Rousseau C, Cochet A, Olivier P, Courbon F, Gontier E, Nataf V, Balogova S, Talbot JN,

PLoS ONE. 2018 ;13(2):e0191487

Performance of 18F-FDG PET/CT in the characterization of adrenal masses in non-cancer patients: A prospective study.

Guerin C, Pattou F, Brunaud L, Lifante JC, Mirallié E, Haissaguerre M, Huglo D, Olivier P, Houzard C, Ansquer C, Hindié E, Loundou A, Archange C, Tabarin A, Sebag F, Baumstarck K, Taïeb D

J. Clin. Endocrinol. Metab.. 2017 Apr;:

Phase II study of a radiotherapy total dose increase in hypoxic lesions identified by F-miso PET/CT in patients with non-small cell lung carcinoma [RTEP5 study].

Vera P, Thureau S, Chaumet-Riffaud P, Modzelewski R, Bohn P, Vermandel M, Hapdey S, Pallardy A, Mahé MA, Lacombe M, Boisselier P, Guillemard S, Olivier P, Beckendorf V, Salem N, Charrier N, Chajon E, Devillers A, Aide N, Danhier S, Denis F, Muratet JP, Martin E, Berriolo-Riedinger A, Kolesnikov-Gauthier H, Dansin E, Massabeau C, Courbon F, Farcy-Jacquet MP, Kotzki PO, Houzard C, Mornex F, Vervueren L, Paumier A, Fernandez P, Salaun M, Dubray B

J. Nucl. Med.. 2017 Mar;:

Limited effectiveness of patent blue dye in addition to isotope scanning for identification of sentinel lymph nodes: Cross-sectional real-life study in 1024 breast cancer patients.

Rauch P, Merlin JL, Leufflen L, Salleron J, Harlé A, Olivier P, Marchal F

Int J Surg. 2016 Sep;33 Pt A:177-81

[Positron emission tomography using fluorine-18-deoxyglucose and diagnosis of deep venous thrombosis recurrence].

Risse J, Martin-Bertaux A, Nicolas A, Olivier P, Wahl D

Presse Med. 2016 Feb;45(2):271-3

Multimodality evaluation of musculoskeletal sarcoidosis: Imaging findings and literature review.

Aptel S, Lecocq-Teixeira S, Olivier P, Regent D, Teixeira PG, Blum A

Diagn Interv Imaging. 2016 Jan;97(1):5-18

Correlation of SUV-Derived Indices With Tumoral Aggressiveness of Gliomas in Static 18F-FDOPA PET: Use in Clinical Practice.

Janvier L, Olivier P, Blonski M, Morel O, Vignaud JM, Karcher G, Taillandier L, Verger A

Clin Nucl Med. 2015 Jul 22.

(1)(8)F-fluorodeoxyglucose positron emission tomography combined with whole-body computed tomographic angiography in critically ill patients with suspected severe sepsis with no definite diagnosis.

Mandry D, Tatopoulos A, Chevalier-Mathias E, Lemarie J, Bollaert PE, Roch V, Olivier P, Marie PY, Gibot S

Eur J Nucl Med Mol Imaging. 2014 Oct;41(10):1924-30

FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2).

Vera P, Mezzani-Saillard S, Edet-Sanson A, Menard JF, Modzelewski R, Thureau S, Meyer ME, Jalali K, Bardet S, Lerouge D, Houzard C, Mornex F, Olivier P, Faure G, Rousseau C, Mahe MA, Gomez P, Brenot-Rossi I, Salem N, Dubray B

Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1057-65

Interobserver agreement of qualitative analysis and tumor delineation of 18F-fluoromisonidazole and 3'-deoxy-3'-18F-fluorothymidine PET images in lung cancer.

Thureau S, Chaumet-Riffaud P, Modzelewski R, Fernandez P, Tessonnier L, Vervueren L, Cachin F, Berriolo-Riedinger A, Olivier P, Kolesnikov-Gauthier H, Blagosklonov O, Bridji B, Devillers A, Collombier L, Courbon F, Gremillet E, Houzard C, Caignon JM, Roux J, Aide N, Brenot-Rossi I, Doyeux K, Dubray B, Vera P

J Nucl Med. 2013 Sep;54(9):1543-50

Radiotherapy for pain: modality of action and indications.

Faivre JC, Janvier L, Berger A, Mathias E, Olivier P, Bensadoun RJ, Peiffert D

Douleur Analg. 2013 Sep;26(3):152-7.

The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3).

Palie O, Michel P, Menard JF, Rousseau C, Rio E, Bridji B, Benyoucef A, Meyer ME, Jalali K, Bardet S, M'vondo CM, Olivier P, Faure G, Itti E, Diana C, Houzard C, Mornex F, Di Fiore F, Vera P

Eur J Nucl Med Mol Imaging. 2013 Sep;40(9):1345-55

A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer.

Nilsson S, Strang P, Aksnes AK, Franzen L, Olivier P, Pecking A, Staffurth J, Vasanthan S, Andersson C, Bruland OS

Eur J Cancer. 2012 Mar;48(5):678-86

Interest of (18)FDG PET/CT for etiological investigation of paraneoplastics syndromes.

Roux V, Olivier P, Taillandier L, Louis S, Sauvee M, Karcher G

. 2011 Dec;35(12):641-51.

Does the association of (18)F-FDG uptake intensity and lesion topography reveal histological phenotype and tumor differentiation in esophageal cancer?

Imperiale A, Cimarelli S, Brigand C, Faure G, Karcher G, Rohr S, Atlani D, Olivier P

Hell J Nucl Med. 2011 Sep;14(3):239-42.

[Metastatic paraganglioma. Answer to May e-quid].

Oldrini G, Geoffrois L, Olivier P, Henrot P, Blum A

J Radiol. 2011 Jul-Aug;92(7-8):739-43.

[Impact of whole body magnetic resonance imaging (MRI) in the management of melanoma patients, in comparison with positron emission tomography/computed tomography (TEP/CT) and CT].

Dellestable P, Granel-Brocard F, Rat AC, Olivier P, Regent D, Schmutz JL

Ann Dermatol Venereol. 2011 May;138(5):377-83

Is (18)FDG PET-CT useful for detecting occult nodal metastases in patients with cutaneous head and neck melanoma, in addition to sentinel lymph node biopsy?.

Revel A, Revel C, Dolivet G, Gillet N, Didot N, Meneroux B, Marie PY, Karcher G, Olivier P

Med Nucl-imag Fonct Metab. 2010 Sep;34(9):528-39.

Evaluation of a rat knee mono-arthritis using microPET.

Paquet J, Maskali F, Poussier S, Scala Bertola J, Pinzano A, Grossin L, Netter P, Olivier P, Gillet P

Biomed Mater Eng. 2010 Jan 1;20(3):195-202.

Development and application of a real-time on-line blinded independent central review of interim PET scans to determine treatment allocation in lymphoma trials.

Meignan M, Itti E, Bardet S, Lumbroso J, Edeline V, Olivier P, Borght TV, Reman O, Karcher G, Mundler O, Mounier N, Ricci R, Federico M, Raemaekers J, Andre M

J Clin Oncol. 2009 Jun 1;27(16):2739-41

Diffuse bone marrow uptake in F-18-FDG-PET in cancer patients: Interpretation and comparison with MRI results

Daragon N, Olivier P, Bruot O, Laurent V, Netter F, Journo A, Karcher G, Scigliano S

Med Nucl-imag Fonct Metab. 2009 Apr;33(4):181-92

SPECT/CT imaging of lung perfusion in the diagnosis of pulmonary embolism: Comparison with planar ventilation-perfusion lung scintigraphy

Revel C, Poisson T, Revel A, Daragon N, Grandpierre S, Netter F, Scigliano S, Djaballah W, Olivier P, Karcher G, Marie PY

Med Nucl-imag Fonct Metab. 2008 Jun;32(6):313-22

Bone metastases from differentiated thyroid carcinoma

Muresan MM, Olivier P, Leclere J, Sirveaux F, Brunaud L, Klein M, Zarnegar R, Weryha G

Endocr Relat Cancer. 2008 Mar;15(1):37-49.

Imaging and PET-CT evaluation of GI tract cancers

Laurent V, Olivier P

J Radiol. 2008 Mar;89(3 Pt 2):413-35; quiz 436-7.

Evaluation of the diagnostic performance of SPECT coupled to tomodensitometry (SPECT-CT) in the daily practice of bone scintigraphy at the Nuclear Medical station of Nancy

Netter F, Journo A, Mayer JC, Grandpierre S, Daragon N, Karcher G, Olivier P, Scigliano S

Med Nucl-imag Fonct Metab. 2008 Feb;32(2):76-84

A particular form of septic arthritis: septic arthritis of facet joint.

Michel-Batot C, Dintinger H, Blum A, Olivier P, Laborde F, Bettembourg-Brault I, Pourel J, Loeuille D, Chary-Valckenaere I

Joint Bone Spine. 2008 Jan;75(1):78-83

Results of preoperative lymphoscintigraphy for breast cancer are predictive of identification of axillary sentinel lymph nodes.

Marchal F, Rauch P, Morel O, Mayer JC, Olivier P, Leroux A, Verhaeghe JL, Guillemin F

World J Surg. 2006 Jan;30(1):55-62.

OSEM reconstruction, associated with temporal fourier and depth-dependant resolution recovery filtering, enhances results from sestamibi and 201Tl 16-interval gated SPECT.

Marie PY, Djaballah W, Franken PR, Vanhove C, Muller MA, Boutley H, Poussier S, Olivier P, Karcher G, Bertrand A

J Nucl Med. 2005 Nov;46(11):1789-95.

Effect of proteoglycan depletion on T2 mapping in rat patellar cartilage.

Watrin-Pinzano A, Ruaud JP, Olivier P, Grossin L, Gonord P, Blum A, Netter P, Guillot G, Gillet P, Loeuille D

Radiology. 2005 Jan;234(1):162-70

Gated SPECT assessment of left ventricular function is sensitive to small patient motions and to low rates of triggering errors: a comparison with equilibrium radionuclide angiography.

Djaballah W, Muller MA, Bertrand AC, Marie PY, Chalon B, Djaballah K, Olivier P, Codreanu A, Karcher G, Bertrand A

J Nucl Cardiol. 2005 Jan-Feb;12(1):78-85.

Fiche personne

Coordonnées

Territoire

Statut

Affiliation

Équipes/plateformes

Recherche

Publications

Retrouvez aussi